by Raynovich Rod | Oct 19, 2015 | Biopharmaceuticals
October 21 Update 9:45a EDT NASDAQ up 0.4% IBB up 1.57% 1:45p EDT Biotech Thrashing Continues-High Fliers Hit Hardest Healthcare stocks remain under attack with the XLV down 1.5% and the IBB down 1.6%.Healthcare is the sector loser down 2% while the Industrials are...
by Raynovich Rod | Oct 18, 2015 | Biopharmaceuticals
10/21 I will be posting articles from the Meeting later this week and next week. 2015 Bio Investor Forum October 20-21, 2015 We will be attending the Bio Investor Forum 2015 in San Francisco next week. Various panels will cover important biotherapy topics such as...
by Raynovich Rod | Oct 13, 2015 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Life Science ETF's and Mutual Funds
10/15 After the Close… XBI Up 7.26%…Green Screen…MOmentum is back Biotech stocks soared today in a broad rally showing a good appetite especially for small and mid-cap stocks. This could be a counter-trend rally in a biotech bear market but there is...
by Raynovich Rod | Sep 29, 2015 | Biopharmaceuticals
Another Rally from FED minutes…except biotech 10/8/15 … BIOTECH-Another test near 2015 lows in early AM ; choppy downtrend but look for a bottoming process as market is turning up toward close: IBB at 306 down slightly after reversal XBI down 1.7% to 63.3...
by Raynovich Rod | Sep 25, 2015 | Biopharmaceuticals
After the close 9/25…The bio-bubble has burst. XBI down 6.85%, IBB down 4.91%. Can healthcare sector recover? —– Bull Market Intact But Sentiment Has Turned Negative The severe 20%++ correction in the biotech sector is getting a lot of bearish...
by Raynovich Rod | Sep 21, 2015 | Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update-1… 9/22/15 …Biotech Stocks Trade Down Another Day Biotech stocks were weak tracking NASDAQ which was down 1.5%. The IBB was down 1.49% to $335.40 flat over one month and up 10.57% YTD. The August low was $325 and the IBB is 16% off July 20 highs....
by Raynovich Rod | Sep 11, 2015 | Biopharmaceuticals
Update-1… 3P September 17 after FED Says No Rate Hike-Biotechs Rally NASDAQ up 0.8% after initial surge Apparently biotech stocks are sensitive to interest rate hikes as many analysts have suggested. Biotech companies need a continual inflow of capital and would...
by Raynovich Rod | Sep 1, 2015 | Biopharmaceuticals
Update -2… 9/8 Rally Time Today Forecasted by Friday’s Action ETF Summary -One month and YTD % FBT (12.36), +9.2% IBB (8.9), +11.3% XBI (10.12), +17.27% The five star Fidelity Select Biotech Portfolio (FBIOX) pretty much tracks the IBB up 11.66% YTD and...
by Raynovich Rod | Aug 27, 2015 | Biopharmaceuticals
Biotech ETFs Rally Back This Week 8/28 After Close The IBB closed at 353.28 up 0.68% and up 3.95% over 5 days. Next week we will provide an analysis of three ETFs -FBT,IBB and XBI- compared to one large fund the Fidelity Select Biotech Portfolio (FBIOX). All of the...
by Raynovich Rod | Aug 24, 2015 | Biopharmaceuticals
Nowhere to Hide in Another 4% Correction 8/25/15 Futures Look Promising at 11p EDT; NIKKEI 225 UP 4.8% Today’s market reached epic proportions of volatility and extremes exacerbated by a DOW opening “flash crash” off 1100 points that distorted faith...